跳至主要内容
临床试验/NCT00168584
NCT00168584已完成4 期

Randomised Study of the Impact of Different Doses of Vitamin A on Childhood Morbidity and Mortality

Bandim Health Project1 个研究点 分布在 1 个国家目标入组 5,400 人开始时间: 2002年11月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
5,400
试验地点
1
主要终点
Mortality

研究概览

简要总结

Vitamin A supplementation reduces all-cause mortality. It is therefore given with oral polio vaccine in national campaigns. However, it is not clear which dose is optimal. The two studies that have investigated the impact of different doses of vitamin A have both found that a smaller dose was better than a large dose. We therefore investigated if a smaller dose given with oral polio vaccine gives equal or better effect.

详细描述

Vitamin A supplementation (VAS) to children above 6 months of age reduces all-cause mortality with 23 %1 to 30 % in low-income countries. WHO recommends VAS at vaccination contacts. The currently recommended doses to be administered every 3-6 months are 100,000 IU for infants between 6 and 11 months of age and 200,000 IU for children 12 months and older. There is no clear evidence that a large dose is better than a small dose, the tendency being the opposite in the two studies of different doses of VAS that have been published so far.

With the global effort to eradicate polio, national immunization days with oral polio vaccine (OPV) offer an additional opportunity to provide vitamin A. In Guinea-Bissau, a combined OPV and VAS campaign took place in November 2002. Given the uncertainty about the best dose of VAS, we aimed to examine whether the dose of vitamin A currently recommended by WHO or half this dose gives a better protection against childhood morbidity and mortality.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
6 Months 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Between 6 mo and 5 years old and thus eligible for OPV and vitamin A during national immunisation day

排除标准

  • Children with overt signs of vitamin A deficiency will not be enrolled in the study, but treated according to the recommendations. -

结局指标

主要结局

Mortality

Hospitalisations

Morbidity

Growth

次要结局

  • Rotavirus infection

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验